Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tshego Maotwe"'
Autor:
Rebecca Howett, Emily A. Krogstad, Opelo Badubi, Alida M. Gertz, Caitlin Bawn, Aamirah Mussa, Tiroyaone Kgaswanyane, Sifelani Malima, Tshego Maotwe, Lesego Mokganya, Doreen Ramogola-Masire, Chelsea Morroni
Publikováno v:
Frontiers in Global Women's Health, Vol 2 (2021)
Introduction: This study explored implant user and healthcare provider experiences of accessing and providing contraceptive implant removal services in Gaborone, Botswana, following introduction of the implant in the public sector in 2016. We sought
Externí odkaz:
https://doaj.org/article/1437da3d5e39478da7f92a8cdb9d1c0b
Autor:
Aamirah Mussa, Ontiretse Sickboy, Alida M. Gertz, Paul G. Whittaker, Lois Hawkins, Tshego Maotwe, Courtney A. Schreiber, Opelo Badubi, Chelsea Morroni, Doreen Ramagola-Masire
Publikováno v:
Int J Gynaecol Obstet
Objective: To create and assess a clinic model to address the unmet need for effective contraception among women living with HIV in Botswana, where half of all pregnancies are unintended and 30% of women of reproductive age are living with HIV. Metho
Autor:
Rebecca, Howett, Alida M, Gertz, Tiroyaone, Kgaswanyane, Gregory, Petro, Lesego, Mokganya, Sifelani, Malima, Tshego, Maotwe, Melanie, Pleaner, Chelsea, Morroni
Publikováno v:
African journal of reproductive health. 23(4)
The use of the subdermal contraceptive implant is increasing globally, and particularly so in lower- and middle-income countries in sub-Saharan Africa. For initiation or discontinuation of the implant, users need to have access to services for insert
Autor:
Alida M. Gertz, Kwana Lechiile, Carolyn Westhoff, Ava Avalos, Aamirah Mussa, Leabaneng Tawe, Tshego Maotwe, Boikhutso Simon, Lesego Mokganya, Sifelani Malima, Nicholas Teodoro, Ian J. Bishop, Serena Liu, Chelsea Morroni
Publikováno v:
Contraception. 102(3)
Objectives To evaluate whether etonogestrel concentrations are reduced to a level that could potentially reduce contraceptive efficacy when the etonogestrel contraceptive implant is used concomitantly with dolutegravir-based antiretroviral therapy (A